Barrow Hanley Mewhinney & Strauss LLC Merck & Co., Inc. Transaction History

Barrow Hanley Mewhinney & Strauss LLC

  • $27.8 Billion
  • Q2 2024

A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 5,891,756 shares of MRK stock, worth $670 Million. This represents 2.63% of its overall portfolio holdings.

Number of Shares
5,891,756
Previous 6,182,460 4.7%
Holding current value
$670 Million
Previous $816 Million 10.59%
% of portfolio
2.63%
Previous 2.92%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$123.8 - $132.96 $36 Million - $38.7 Million
-290,704 Reduced 4.7%
5,891,756 $729 Million
Q1 2024

May 13, 2024
SELL
$113.24 - $131.95 $40.4 Million - $47.1 Million
-357,187 Reduced 5.46%
6,182,460 $816 Million
Q4 2023

Feb 12, 2024
SELL
$100.18 - $109.02 $140,352 - $152,737
-1,401 Reduced 0.02%
6,539,647 $713 Million
Q3 2023

Nov 13, 2023
SELL
$102.95 - $114.33 $7.59 Million - $8.43 Million
-73,762 Reduced 1.12%
6,541,048 $673 Million
Q2 2023

Aug 10, 2023
SELL
$108.61 - $118.38 $171 Million - $187 Million
-1,577,768 Reduced 19.26%
6,614,810 $763 Million
Q1 2023

May 11, 2023
SELL
$102.94 - $114.86 $129 Million - $144 Million
-1,254,396 Reduced 13.28%
8,192,578 $872 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $60.3 Million - $77.4 Million
-690,099 Reduced 6.81%
9,446,974 $1.05 Billion
Q3 2022

Nov 10, 2022
SELL
$84.53 - $94.96 $67 Million - $75.3 Million
-792,510 Reduced 7.25%
10,137,073 $873 Million
Q2 2022

Aug 11, 2022
SELL
$83.49 - $94.64 $11.1 Million - $12.6 Million
-133,528 Reduced 1.21%
10,929,583 $996 Million
Q1 2022

May 13, 2022
BUY
$73.51 - $82.4 $43.4 Million - $48.6 Million
590,396 Added 5.64%
11,063,111 $908 Million
Q4 2021

Feb 10, 2022
BUY
$72.28 - $90.54 $18.9 Million - $23.6 Million
261,025 Added 2.56%
10,472,715 $803 Million
Q3 2021

Nov 12, 2021
BUY
$71.68 - $78.83 $4.73 Million - $5.21 Million
66,038 Added 0.65%
10,211,690 $767 Million
Q2 2021

Aug 12, 2021
BUY
$70.31 - $77.77 $663 Million - $734 Million
9,433,323 Added 1324.29%
10,145,652 $789 Million
Q1 2021

May 13, 2021
BUY
$68.86 - $81.11 $46.3 Million - $54.5 Million
672,310 Added 1679.98%
712,329 $54.9 Million
Q4 2020

Feb 11, 2021
SELL
$71.77 - $79.65 $36,889 - $40,940
-514 Reduced 1.27%
40,019 $3.27 Million
Q3 2020

Nov 12, 2020
SELL
$73.18 - $82.95 $1.83 Million - $2.07 Million
-24,941 Reduced 38.09%
40,533 $3.36 Million
Q4 2019

Feb 12, 2020
SELL
$77.58 - $87.54 $44.6 Million - $50.4 Million
-575,523 Reduced 89.79%
65,474 $5.96 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $80.5 Million - $87.7 Million
-1,057,464 Reduced 62.26%
640,997 $54 Million
Q2 2019

Aug 13, 2019
SELL
$69.84 - $81.59 $10.9 Million - $12.8 Million
-156,733 Reduced 8.45%
1,698,461 $142 Million
Q1 2019

May 14, 2019
SELL
$69.58 - $79.36 $94.9 Million - $108 Million
-1,363,848 Reduced 42.37%
1,855,194 $154 Million
Q4 2018

Feb 13, 2019
SELL
$65.24 - $75.71 $160 Million - $185 Million
-2,448,914 Reduced 43.21%
3,219,042 $246 Million
Q3 2018

Nov 13, 2018
SELL
$57.69 - $67.84 $45.3 Million - $53.3 Million
-785,008 Reduced 12.17%
5,667,956 $402 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $322 Million - $378 Million
-6,325,013 Reduced 49.5%
6,452,964 $392 Million
Q1 2018

May 14, 2018
SELL
$50.96 - $59.23 $72.8 Million - $84.6 Million
-1,429,052 Reduced 10.06%
12,777,977 $696 Million
Q4 2017

Feb 09, 2018
SELL
$51.62 - $61.64 $47.3 Million - $56.4 Million
-915,673 Reduced 6.05%
14,207,029 $799 Million
Q3 2017

Nov 13, 2017
BUY
$58.67 - $63.13 $887 Million - $955 Million
15,122,702
15,122,702 $968 Million

Others Institutions Holding MRK

# of Institutions
3,830
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Barrow Hanley Mewhinney & Strauss LLC Portfolio

Follow Barrow Hanley Mewhinney & Strauss LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email